Form 4 for ATRC AtriCure, Inc.
Accepted 2023-01-03 00:00:00 ET · period of report 2022-12-30 · accession 0001323885-23-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-03 | 2022-12-30 | ATRC | Noznesky Justin J | Chief Mktg, Strategy Off | A - Grant | $34.86 | +585 | 38.4K | +2% | +$20.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-30 | A | A | 585 | $34.86 | 38,414 | D | — | — | (F1) Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended December 31, 2022. (F2) In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 1, 2022, which is the first trading day of the applicable offering period. The closing price on July 1, 2022 was $41.01. |